{"schema_version":"secwatch.filing_event.v1","accession":"0000896264-25-000213","form_type":"8-K","ticker":"USNA","cik":"0000896264","company_name":"USANA HEALTH SCIENCES INC","filed_at":"2025-10-22T23:59:59+00:00","discovered_at":"2026-05-14T18:02:42.533143+00:00","generated_at":"2026-05-17T02:55:02.008549+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"USANA Q3 net loss of $6.5M; lowers FY25 EPS guidance to $0.78 from $1.50-$2.20","bullets":["Net sales $214M (+7% YoY) but net loss -$6.5M vs +$10.6M prior year; adj. diluted EPS -$0.15.","Direct selling active customers down 14% to 388,000; Hiya subscribers 193,400 (down 3% sequentially).","FY25 guidance cut sharply: diluted EPS $0.78 (prev $1.50-$2.20); adj. diluted EPS $1.73 (prev $2.35-$3.00).","Effective tax rate jumped to 65% from 45%, causing ~$7.6M income tax expense adjustment in Q3.","Company expects $4.7M restructuring charge in Q4 to align costs with sales; cash $145M, no debt."],"urls":{"canonical":"https://secwatch.observer/filing/0000896264-25-000213","json":"https://secwatch.observer/filing/0000896264-25-000213.json","markdown":"https://secwatch.observer/filing/0000896264-25-000213.md","text":"https://secwatch.observer/filing/0000896264-25-000213.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/896264/000089626425000213/0000896264-25-000213-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/896264/000089626425000213/usna-20251022.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T02:55:02.008549+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}